Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Catalio Capital Management, LP (CIK 1958125) reported $532.1M across 39 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: AVLN ($55.2M, 10.37%), JNJ ($35.3M, 6.63%), GILD ($34.0M, 6.39%), BBIO ($33.9M, 6.37%), SNDX ($26.6M, 4.99%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AVLN | AVALYN PHARMACEUTICALS INC | $55.2M | 10.37% | 1.7M | New |
| 2 | JNJ | JOHNSON & JOHNSON | $35.3M | 6.63% | 138,946 | New |
| 3 | GILD | GILEAD SCIENCES INC | $34.0M | 6.39% | 269,309 | Added |
| 4 | BBIO | BRIDGEBIO PHARMA INC | $33.9M | 6.37% | 455,041 | Added |
| 5 | SNDX | SYNDAX PHARMACEUTICALS INC | $26.6M | 4.99% | 1.2M | Added |
| 6 | DFTX | DEFINIUM THERAPEUTICS INC | $26.5M | 4.97% | 562,672 | Trimmed |
| 7 | BMY | BRISTOL-MYERS SQUIBB CO | $23.8M | 4.47% | 412,961 | Trimmed |
| 8 | PBLS | PARABILIS MEDICINES INC | $22.6M | 4.24% | 824,043 | New |
| 9 | NTRA | NATERA INC | $22.3M | 4.19% | 82,181 | Added |
| 10 | INCY | INCYTE CORP | $21.7M | 4.08% | 191,627 | Added |
| 11 | SEPN | SEPTERNA INC | $18.0M | 3.37% | 536,152 | Added |
| 12 | MLYS | MINERALYS THERAPEUTICS INC | $17.5M | 3.29% | 648,722 | Added |
| 13 | HTFL | HEARTFLOW INC | $17.1M | 3.21% | 583,055 | Added |
| 14 | CRVS | CORVUS PHARMACEUTICALS INC | $16.1M | 3.03% | 1.1M | Added |
| 15 | GPCR | STRUCTURE THERAPEUTICS INC | $14.8M | 2.79% | 276,550 | Added |
| 16 | PTGX | PROTAGONIST THERAPEUTICS INC | $13.1M | 2.46% | 106,799 | New |
| 17 | IRON | DISC MEDICINE INC | $11.7M | 2.19% | 159,384 | Added |
| 18 | EW | EDWARDS LIFESCIENCES CORP | $11.3M | 2.12% | 124,778 | Trimmed |
| 19 | AXSM | AXSOME THERAPEUTICS INC. | $10.6M | 1.99% | 43,182 | New |
| 20 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $10.6M | 1.98% | 316,252 | Trimmed |
| 21 | KLRA | KAILERA THERAPEUTICS INC | $10.3M | 1.94% | 468,750 | New |
| 22 | KPTI | KARYOPHARM THERAPEUTICS INC | $9.2M | 1.73% | 940,855 | Added |
| 23 | ODTX | ODYSSEY THERAPEUTICS INC | $8.6M | 1.61% | 457,839 | New |
| 24 | ASND | ASCENDIS PHARMA A/S | $8.5M | 1.59% | 31,759 | New |
| 25 | KARD | KARDIGAN INC | $7.5M | 1.40% | 312,500 | New |
Source: SEC Form 13F filings · as of 2026-06-30